|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
10,820,000 |
Market
Cap: |
1.30(B) |
Last
Volume: |
401,241 |
Avg
Vol: |
400,142 |
52
Week Range: |
$115.55 - $119.99 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Heska sells veterinary and animal health diagnostic and specialty products. Co.'s primary focus is on the canine and feline healthcare space. Co.'s business is composed of two segments: North America and International. Co.'s main product categories sold in both segments include: Point of Care laboratory instruments and consumables; digital imaging diagnostic instruments, software and services; digital cytology services; local and cloud-based data services; allergy testing and immunotherapy; and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
14,458 |
Total Buy Value |
$0 |
$0 |
$0 |
$851,078 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
2 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Mcginley Michael J |
Presi, Biologic. & Pharm. |
|
2017-05-31 |
4 |
S |
$98.53 |
$1,102,434 |
D/D |
(11,189) |
106,747 |
|
- |
|
Lippincott Rod |
EVP, Comp. Animal Health Sales |
|
2017-05-31 |
4 |
S |
$98.00 |
$438,158 |
D/D |
(4,471) |
9,814 |
|
- |
|
Lippincott Rod |
EVP, Comp. Animal Health Sales |
|
2017-05-31 |
4 |
OE |
$39.76 |
$209,202 |
D/D |
4,471 |
10,764 |
|
- |
|
Lippincott Rod |
EVP, Comp. Animal Health Sales |
|
2017-05-26 |
4 |
S |
$98.00 |
$662,111 |
D/D |
(6,756) |
9,814 |
|
- |
|
Lippincott Rod |
EVP, Comp. Animal Health Sales |
|
2017-05-26 |
4 |
OE |
$7.36 |
$90,016 |
D/D |
6,756 |
9,914 |
|
- |
|
Napolitano Jason A |
COO, Chief Strategist and Sec. |
|
2017-05-24 |
4 |
S |
$100.50 |
$502,500 |
D/D |
(5,000) |
32,119 |
|
- |
|
Wisnewski Nancy |
EVP, Diag. Ops & Prod. Dev. |
|
2017-05-24 |
4 |
S |
$100.17 |
$25,042 |
D/D |
(250) |
38,901 |
|
- |
|
Wrenn Carol |
Director |
|
2017-05-23 |
4 |
S |
$96.93 |
$158,024 |
D/D |
(1,630) |
4,544 |
|
- |
|
Wrenn Carol |
Director |
|
2017-05-23 |
4 |
OE |
$8.10 |
$13,203 |
D/D |
1,630 |
6,174 |
|
- |
|
Mcmahon John |
VP, Chief Financial Officer |
|
2017-05-23 |
4 |
S |
$96.93 |
$56,940 |
D/D |
(587) |
0 |
|
- |
|
Mcmahon John |
VP, Chief Financial Officer |
|
2017-05-23 |
4 |
OE |
$28.39 |
$15,159 |
D/D |
417 |
462 |
|
- |
|
Riley Sharon L. |
Director |
|
2017-05-04 |
4 |
B |
$90.00 |
$90,000 |
D/D |
1,000 |
3,294 |
2.39 |
- |
|
Trowbridge Bonnie J. |
Director |
|
2017-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
544 |
544 |
|
- |
|
Gordon G Irwin |
Director |
|
2017-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
544 |
32,901 |
|
- |
|
Gordon G Irwin |
Director |
|
2017-05-01 |
4 |
D |
$110.24 |
$169,218 |
D/D |
(1,535) |
32,357 |
|
- |
|
Gordon G Irwin |
Director |
|
2017-05-01 |
4 |
OE |
$6.66 |
$245,660 |
D/D |
19,016 |
33,073 |
|
- |
|
Sveen David E. |
Director |
|
2017-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
544 |
7,768 |
|
- |
|
Wrenn Carol |
Director |
|
2017-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
544 |
4,544 |
|
- |
|
Riley Sharon L. |
Director |
|
2017-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
544 |
2,294 |
|
- |
|
Napolitano Jason A |
COO, Chief Strategist and Sec. |
|
2017-04-11 |
4 |
AS |
$100.73 |
$20,146 |
D/D |
(200) |
37,119 |
|
- |
|
Napolitano Jason A |
COO, Chief Strategist and Sec. |
|
2017-04-10 |
4 |
AS |
$103.33 |
$93,137 |
D/D |
(900) |
37,319 |
|
- |
|
Napolitano Jason A |
COO, Chief Strategist and Sec. |
|
2017-04-10 |
4 |
AS |
$100.75 |
$401,482 |
D/D |
(3,900) |
38,219 |
|
- |
|
Wisnewski Nancy |
EVP, Diag. Ops & Prod. Dev. |
|
2017-03-09 |
4 |
S |
$96.64 |
$48,321 |
D/D |
(500) |
39,151 |
|
- |
|
Mcmahon John |
VP, Chief Financial Officer |
|
2017-03-09 |
4 |
S |
$97.42 |
$68,973 |
D/D |
(708) |
75 |
|
- |
|
Mcmahon John |
VP, Chief Financial Officer |
|
2017-03-09 |
4 |
OE |
$28.39 |
$26,729 |
D/D |
708 |
658 |
|
- |
|
465 Records found
|
|
Page 12 of 19 |
|
|